Dr. Michael Bissell serves as the director of the Division of Clinical Chemistry, Special Functions and Toxicology. The clinical chemistry laboratory’s focus on quality control continues with ongoing implementation of the BioRad Unity Realtime software application, and this year planning for a potential major update of the Beckman-Coulter/IDS automation line and analyzers was begun in the Critical Care Lab. Automation of immunochemistry platforms in the special functions laboratory continues to advance particularly for the infectious and autoimmune serology test menu (syphilis and ANA panels), and automated human papilloma virus (HPV) PCR assays have been implemented in this laboratory. In Toxicology, full-time implementation of LC/MS/MS technology for comprehensive urine and serum drug panels has been successfully implemented and Vitamin D testing has been effectively in-sourced. Drug testing menus have been expanded towards accommodating the needs of pain management and other clients concerned with compliance and diversion of prescription drugs.
Dr. Bissell continues to serve as Medical Review Officer for OSUMC's faculty/housestaff workplace drug testing program, and as Custodian of Records for the Toxicology Laboratory’s forensic drug testing program, providing court testimony throughout Ohio. Dr. Bissell served on several OSUMC Committees including the Pharmacy & Therapeutics Executive Committee, and is Vice-Chair of the College of American Pathologists Toxicology Resource Committee, with whom he is author/editing a major new textbook in clinical toxicology to be released by CAP Press in 2011-2012 and entitled Clinical Toxicology Testing: A Guide for Laboratory Professionals. He is also entering his eleventh year as Editor/Author of the Yearbook of Pathology and Laboratory Medicine and as contributing editor of CAP TODAY.